Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
FDA Approvals
Nesina, Kazano, and Oseni: Three Alogliptin-Based Agents Approved for the Treatment of Type 2 Diabetes
Read More
FDA Approvals
GLP-1 Agonists May Protect Patients with Diabetes from Heart Failure
Read More
FDA Approvals
Breo Ellipta: A Fixed-Dose Combination Oral Inhaler Receives FDA Approval for Long-Term Maintenance Treatment of COPD
Read More
FDA Approvals
Invokana (Canagliflozin): First-in-Class SGLT2 Inhibitor Approved for the Treatment of Type 2 Diabetes
Read More
Highlights from the ADA President’s Research Sessions
Read More
Look AHEAD: Lifestyle Intervention Cost-Effective in Overweight Patients with Type 2 Diabetes
Read More
FDA Approvals
SGLT-2 Inhibitors Show Durability in Glycemic Control, Weight-Loss Maintenance
Read More
Pooled Analysis Confirms CV Benefits of DPP-4 Inhibition
Read More
Adding Linagliptin to Basal Insulin Reduces Hypoglycemia in Older Patients with Type 2 Diabetes
Read More
Novel Predictors of Outcomes in Diabetes
Read More
163
164
165
166
167
168
169
Page 166 of 244
Results 1651 - 1660 of 2436
